ClinicalTrials.Veeva

Menu

Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome

A

Assiut University

Status

Completed

Conditions

Infertility, Male

Treatments

Diagnostic Test: Sperm DNA integrity by flow cytometry

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In the current era of assisted reproductive techniques where technology can help overcome defects in sperm function, the value of semen analysis has become even more inaccurate. Initial reports of intracytoplasmic sperm injection revealed its ability to bypass the natural selection process and enable men with severely impaired semen parameters to achieve both clinical pregnancy and live birth

Enrollment

120 patients

Sex

Male

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Infertile male patients with abnormal semen parameters.
  2. Normal female partner aged <38 years.

Exclusion criteria

  1. Female patients with obvious infertility factor.
  2. Male patients with azoospermia.
  3. Male patients with systemic diseases.
  4. Male patients receiving cytotoxic therapy.
  5. Male patients with genital pathology as cryptorchidism.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems